Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's - PubMed (original) (raw)
Review
Tgf-Beta pathway as a potential target in neurodegeneration and Alzheimer's
Tony Wyss-Coray. Curr Alzheimer Res. 2006 Jul.
Abstract
Alzheimer's disease (AD) is a fatal neurodegenerative disease characterized by the loss of large numbers of forebrain neurons. There are currently no effective AD treatments available and the cause of the disease is unknown in the majority of cases. Because normal neuronal maintenance and survival depends on stimulation of key signaling pathways by a number of neurotrophic factors it has been postulated that reduced signaling by or expression of these factors may promote neurodegeneration. Growing evidence suggests that the transforming growth factor-beta (TGF-beta) signaling pathway may be one such neurotrophic pathway that meets important protective and survival roles in neurons. Here I explore this evidence and discuss the pathway as a potential target for the treatment of neurodegeneration and AD.
Similar articles
- Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology.
Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV, Lin AH, Crews L, Tremblay P, Mathews P, Mucke L, Masliah E, Wyss-Coray T. Tesseur I, et al. J Clin Invest. 2006 Nov;116(11):3060-9. doi: 10.1172/JCI27341. J Clin Invest. 2006. PMID: 17080199 Free PMC article. - Transforming growth factor-beta signaling pathway as a therapeutic target in neurodegeneration.
Wyss-Coray T. Wyss-Coray T. J Mol Neurosci. 2004;24(1):149-53. doi: 10.1385/JMN:24:1:149. J Mol Neurosci. 2004. PMID: 15314264 - A role for TGF-beta signaling in neurodegeneration: evidence from genetically engineered models.
Tesseur I, Wyss-Coray T. Tesseur I, et al. Curr Alzheimer Res. 2006 Dec;3(5):505-13. doi: 10.2174/156720506779025297. Curr Alzheimer Res. 2006. PMID: 17168649 Review. - Dysfunction of TGF-β1 signaling in Alzheimer's disease: perspectives for neuroprotection.
Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A. Caraci F, et al. Cell Tissue Res. 2012 Jan;347(1):291-301. doi: 10.1007/s00441-011-1230-6. Epub 2011 Aug 31. Cell Tissue Res. 2012. PMID: 21879289 Review. - Development of beta-amyloid-induced neurodegeneration in Alzheimer's disease and novel neuroprotective strategies.
Hölscher C. Hölscher C. Rev Neurosci. 2005;16(3):181-212. doi: 10.1515/revneuro.2005.16.3.181. Rev Neurosci. 2005. PMID: 16323560 Review.
Cited by
- Transforming Growth Factor-Beta Signaling in the Neural Stem Cell Niche: A Therapeutic Target for Huntington's Disease.
Kandasamy M, Reilmann R, Winkler J, Bogdahn U, Aigner L. Kandasamy M, et al. Neurol Res Int. 2011;2011:124256. doi: 10.1155/2011/124256. Epub 2011 May 19. Neurol Res Int. 2011. PMID: 21766020 Free PMC article. - Investigation of serum levels of orexin-A, transforming growth factor β, and leptin in patients with multiple sclerosis.
Moharami S, Nourazarian A, Nikanfar M, Laghousi D, Shademan B, Joodi Khanghah O, Khaki-Khatibi F. Moharami S, et al. J Clin Lab Anal. 2022 Jan;36(1):e24170. doi: 10.1002/jcla.24170. Epub 2021 Dec 11. J Clin Lab Anal. 2022. PMID: 34894407 Free PMC article. - Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease.
Farfara D, Lifshitz V, Frenkel D. Farfara D, et al. J Cell Mol Med. 2008 Jun;12(3):762-80. doi: 10.1111/j.1582-4934.2008.00314.x. Epub 2008 Mar 20. J Cell Mol Med. 2008. PMID: 18363841 Free PMC article. Review. - Icariin ameliorates neuropathological changes, TGF-β1 accumulation and behavioral deficits in a mouse model of cerebral amyloidosis.
Zhang ZY, Li C, Zug C, Schluesener HJ. Zhang ZY, et al. PLoS One. 2014 Aug 7;9(8):e104616. doi: 10.1371/journal.pone.0104616. eCollection 2014. PLoS One. 2014. PMID: 25101849 Free PMC article. - Small Molecule Drug C381 Attenuates Brain Vascular Damage Following Repetitive Mild Traumatic Injury.
Li L, Nguyen A, Zhao B, Vest R, Yerra L, Sun B, Luo J. Li L, et al. Neurotrauma Rep. 2024 Oct 22;5(1):1016-1026. doi: 10.1089/neur.2024.0060. eCollection 2024. Neurotrauma Rep. 2024. PMID: 39464529
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical